American Journal of Psychiatry Publishes Minerva Neurosciences' MIN-101 Phase 2b Trial Results for Treatment of Negative Symptoms in Schizophrenia

World News: . []

WALTHAM Mass July 31 2017 GLOBE NEWSWIRE -- LINK  Neurosciences Inc NASDAQNERV a clinical-stage biopharmaceutical company focused on the development of LINK  to treat central nervous LINK  disorders today announced that th e Ameri...

More news and information about Minerva Neurosciences, Inc.

Published By:

Thomson Reuters: 13:30 GMT Monday 31st July 2017

Published: .

Search for other references to "american" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us